APPLICATION
ANDA075367
TYPE
ANDA
ORIGINAL APPROVAL
1999-04-22
LATEST ACTION
2006-03-17
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
JUNIOR STRENGTH IBUPROFENDiscontinued
IBUPROFEN 100MG · TABLET · ORAL
Approval history
2006-03-17Labeling · Supplement 18AP
2001-08-21Manufacturing (CMC) · Supplement 3AP
2001-04-12Labeling · Supplement 2AP
2000-04-27Labeling · Supplement 1AP
1999-04-22OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.